Announcements
Announcement on Change of Financial Officer and Acting Spokesperson
Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, company secretary, research and development officer, or internal audit officer): Financial officer and acting …
Subsidiary AP Biosciences and Tasly Biopharmaceuticals Signed Cooperative Development and Authorized Agreement of New Antibody Drug
Date of occurrence of the event: Jul 29, 2019 Counterparty to the contract or commitment: Tasly Biopharmaceuticals Co. Ltd Relationship to the Company: None Starting and ending dates (or rescission …
Announcement on the Change of Spokesperson
Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, company secretary, research and development officer, or internal audit officer): Spokesperson Date of occurrence …
Announcement of New CEO
Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, company secretary, research and development officer, or internal audit officer): CEO Date of occurrence …
Announcement of 3rd Audit Committee Members
Date of occurrence of the change: Jul 22, 2019 Name of the functional committees: Audit Committee Name and resume of the replaced member: (1)Jerry G. Feng/ Director of Graduate Institute …
Announcement of 4th Payroll Committee Members
Date of occurrence of the change: Jul 22, 2019 Name of the functional committees: Payroll Committee Name and resume of the replaced member: (1)Jerry G. Feng/ Director of Graduate Institute …
Taiwan Shilin District Court appeals against the acquittal of Mr. Michael Chang and five other executives’insider trading case
Parties to the legal matter: Michael Chang (Chairman); Youe-Kong Shue (Former Vice Chairman); Amy Hung (General Manager); Tony Yu (Chief Science Officer); Jon-Jin Liao (Former Medical Business Director) Name of …
Supplementary statement regarding the news article by the Investor and other news media
Date of occurrence of the event: Jun 27, 2019 Company name: OBI Pharma, Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Announcement of the status of implementation of the commitments during the up-listing at over-the-counter market
Date of occurrence of the event: Jun 27, 2019 Company name: OBI Pharma Inc. Relationship to the Company (please enter “head office” or “subsidiaries”): Head office Reciprocal shareholding ratios: N/A …
Company’s Board of Directors nominated Michael Chang to serve as the Chairman of the Board
Date of the board of directors resolution or date of occurrence of the change: Jun 27, 2019 .Type of personnel (chairman or general manager): Chairman Name and resume of the …